Advertisement
Research ArticleMinireviews

Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological Target

Natalie E. Scholpa and Rick G. Schnellmann
Journal of Pharmacology and Experimental Therapeutics December 2017, 363 (3) 303-313; DOI: https://doi.org/10.1124/jpet.117.244806
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleMinireviews

Mitochondrial Biogenesis for Spinal Cord Injury Treatment

Natalie E. Scholpa and Rick G. Schnellmann
Journal of Pharmacology and Experimental Therapeutics December 1, 2017, 363 (3) 303-313; DOI: https://doi.org/10.1124/jpet.117.244806
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement